Tomer Kariv
CIK 1568077 · last filed 2025-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ELOX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
200 ROUTE 31 NORTH, SUITE 104
FLEMINGTON, NJ 08822
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KROS | Director | 160,512 | $11.33 | $1.82M | $7.00M | 8 | 2025-06-11 |
| ELOX | Director | 5,200 | $13.17 | $68.5K | $13.21M | 9 | 2023-01-31 |
| LogicBio Therapeutics, Inc. (LOGC) Delisted | Director | 1,574,564 | $7.06 | $11.12M | $4.20M | 3 | 2019-12-20 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 28,317 | $0.07 | $1.8K | $2.00M | 3 | 2019-02-04 |
Recent Filings · Page 3 of 4
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-19 | ELOX | Grant (A) | — | $0 | EDGAR |
| 2018-05-01 | ELOX | Buy (P) | +350,000 | $3.41M | EDGAR |
| 2018-03-23 | — | Buy (P) | +12,600 | $97.8K | |
| 2018-01-29 | VBI Vaccines Inc/BC (VBIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-17 | — | Buy (P) | +714,285 | $0 | |
| 2016-04-15 | — | Grant (A) | — | $0 | |
| 2016-04-11 | — | Buy (P) | +1,448,062 | $506.8K | |
| 2016-01-14 | — | Buy (P) | +1,448,062 | $506.8K | |
| 2014-01-28 | — | Grant (A) | — | $0 | |
| 2013-11-06 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.